BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30080184)

  • 1. To Use or Not to Use 131I in Thyroid Cancer.
    Metter D; Phillips WT; Walker RC; Blumhardt R
    Clin Nucl Med; 2018 Sep; 43(9):670-671. PubMed ID: 30080184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.
    Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer.
    Slonimsky E; Tulchinsky M
    Curr Pharm Des; 2020; 26(31):3812-3827. PubMed ID: 32503402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
    Claimon A; Pusuwan P; Khiewvan B
    J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.
    Shi ZY; Zhang SX; Fan D; Li CH; Cheng ZH; Xue Y; Wu LX; Lu KY; Yang SY; Cheng Y; Wu ZF; Gao C; Li XF; Liu HY; Li SJ
    Front Immunol; 2022; 13():901263. PubMed ID: 35844520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
    Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma.
    Wang J; Mao Y; Li L; Liang J; Huang H; Lin W; Chen G; Wen J
    Endocrine; 2024 May; ():. PubMed ID: 38809346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of body iodine pool assessment methods before radioiodine therapy.
    Genc M; Yildirim A; Yildirim N
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):107-112. PubMed ID: 38331249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
    Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.
    Hartung-Knemeyer V; Nagarajah J; Jentzen W; Ruhlmann M; Freudenberg LS; Stahl AR; Bockisch A; Rosenbaum-Krumme SJ
    Ann Nucl Med; 2012 Nov; 26(9):723-9. PubMed ID: 22802008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases.
    Yang J; Zheng R; Liang M; Jia Y; Lin L; Geng J; Chen S; Li YX
    Front Oncol; 2019; 9():558. PubMed ID: 31316914
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Seo GH; Cho YY; Chung JH; Kim SW
    Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
    Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.
    Jang EK; Kim WG; Kim HC; Huh JW; Kwon H; Choi YM; Jeon MJ; Kim TY; Shong YK; Ryu JS; Kim WB
    PLoS One; 2015; 10(4):e0125114. PubMed ID: 25923702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry.
    Georgiou MF; Nielsen JA; Chiriboga R; Kuker RA
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
    Kim HO; Lee K; Lee SM; Seo GH
    JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.